| Dr Brian L Van Hoozen, DO | |
|
1505 Mill St, New London, WI 54961-2187 | |
| (920) 982-7900 | |
| (920) 982-7995 |
| Full Name | Dr Brian L Van Hoozen |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 1505 Mill St, New London, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821170986 | NPI | - | NPPES |
| 11014110 | Medicaid | WI | |
| 390848401050 | Other | WI | CMH ANTHEM |
| 30054700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 32699 (Wisconsin) | Secondary |
| 207Q00000X | Family Medicine | 32699 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Medical Center - New London | New london, WI | Hospital |
| Entity Name | Mile Bluff Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609912005 PECOS PAC ID: 8527971399 Enrollment ID: O20031205000618 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has entered into a scientific collaboration with University of California, Los Angeles to research the conversion of dermal fibroblasts into pure functional human cell types that may have greater regenerative capacity.
› Verified 1 days ago
| Entity Name | Brian Van Hoozen Do Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851563472 PECOS PAC ID: 5890969679 Enrollment ID: O20111111000499 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has entered into a scientific collaboration with University of California, Los Angeles to research the conversion of dermal fibroblasts into pure functional human cell types that may have greater regenerative capacity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian L Van Hoozen, DO Po Box 96, New London, WI 54961-0096 Ph: (920) 982-7900 | Dr Brian L Van Hoozen, DO 1505 Mill St, New London, WI 54961-2187 Ph: (920) 982-7900 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has entered into a scientific collaboration with University of California, Los Angeles to research the conversion of dermal fibroblasts into pure functional human cell types that may have greater regenerative capacity.
› Verified 1 days ago
Donn Fuhrmann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 | |
Timothy Houlihan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 | |
Renae Schuler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 | |
Reginald A Ebirim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2000 Fax: 920-531-2098 | |
Felix Jolly Odathil, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2000 Fax: 920-531-2450 | |
Dale L Schlais, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 Algoma St, New London, WI 54961 Phone: 920-982-8300 | |
Joseph Lamb, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 |